Publikationen von Sampurna Chatterjee
Alle Typen
Zeitschriftenartikel (6)
2015
Zeitschriftenartikel
6 (36), S. 38458 - 38468 (2015)
Intermittent high-dose treatment with erlotinib enhances therapeutic efficacy in EGFR-mutant lung cancer. Oncotarget 2014
Zeitschriftenartikel
74 (10), S. 2816 - 2824 (2014)
Transient antiangiogenic treatment improves delivery of cytotoxic compounds and therapeutic outcome in lung cancer. Cancer Research
Zeitschriftenartikel
134 (12), S. 2829 - 2840 (2014)
The bispecific immunoligand ULBP2-aCEA redirects natural killer cells to tumor cells and reveals potent anti-tumor activity against colon carcinoma. International Journal of Cancer 2013
Zeitschriftenartikel
123 (4), S. 1732 - 1740 (2013)
Tumor vegf:vegfr2 autocrine feed-forward loop triggers angiogenesis in lung cancer. Journal of Clinical Investigation 2012
Zeitschriftenartikel
4 (141), 141ra91 (2012)
Targeted expression of mutated ALK induces neuroblastoma in transgenic mice. Science Translational Medicine 2010
Zeitschriftenartikel
143 (2), S. 201 - 211 (2010)
Cytohesins are cytoplasmic ErbB receptor activators. Cell